Saamya Biotech (India) Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of nil against INR 36,676,043 a year ago. Loss from operations from other income, interest and exceptional items was INR 2,643,124 against INR 1,527,552 a year ago. Loss from ordinary activities before and after tax was INR 2,644,391 against INR 1,527,608 a year ago. Net loss for the period was INR 2,644,391 against INR 1,527,608 a year ago. Basic and diluted loss per share was INR 0.11 against INR of 0.06 a year ago.

For the nine months, the company reported net sales/income from operations (net of excise duty) of INR 144,021,942 against INR 36,676,043 a year ago. Loss from operations from other income, interest and exceptional items was INR 7,791,389 against INR 3,291,252 a year ago. Loss from ordinary activities before and after tax was INR 6,835,065 against INR 3,358,570 a year ago. Net loss for the period was INR 6,835,065 against INR 3,358,570 a year ago. Basic and diluted loss per share was INR 0.27 against INR of 0.13 a year ago.